CURRICULUM VITAE

PERSONAL INFORMATION

Name:                                   Carlos Roberto Opazo Martínez
Chilean Passport:                11.805.887-9
Date of birth and place:      December 21st, 1970. Coquimbo, Chile.
Academic degree:                 Bachelor in Biochemistry, P. Universidad Católica de 
                                               Valparaíso (1996).
                                               PhD (Doctor of Biological Sciences), P. Universidad
                                                Católica de Chile (2002).
Professional Title:                Biochemist, P. Universidad Católica de Valparaíso (1996).
Research Position:               Research Fellow, Oxidation Biology Laboratory,
                                               Melbourne Brain Centre (2012 to date)
Work address:                       The Florey Institute of Neuroscience and Mental Health, 
                                                Kenneth Myer Building, 30 Royal Parade, The University of  
                                                Melbourne, Parkville,Victoria 3010, Melbourne, Australia
Work phone number:           (613) 834 44125
Mobile phone number:         (613) 499790121
e-mail:                                     carlos.opazo@florey.edu.au; carlos.opazo@unimelb.edu.au
Date:                                       April 2020


WORK EXPERIENCE:


1. TENURE EXPERIENCE AT THE UNIVERSITY:
-January 2005- December 2009: Assistant Professor at the Department of Physiology, Faculty of Sciences, University of Concepción, Concepción, Chile.
-January 2010- August 2012: Associate Professor at the Department of Physiology, Faculty of Sciences, University of Concepción, Concepción, Chile.
-March 2010-July 2011: Director of PhD Program in Biological Sciences, Facultad de Ciencias Biológicas, Universidad de Concepción, Chile.
-January 2010-August 2012: Executive Director CMA Bío Bío, Universidad de Concepción, Chile.
-September 2012- to date: Senior Research Officer, The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Melbourne, Australia.


2. HONORARY POSITION AT THE UNIVERSITY:
-July 2016- up to date: Honorary Senior Fellow, Department of Psychiatry, The University of Melbourne.

3. POSDOCTORAL EXPERIENCE:
-September 2002 -December 2004: Senior Research Assistant at the Oxidation Disorders Laboratory, Mental Health Research Institute of Victoria and Department of Pathology, The University of Melbourne. Melbourne, Australia. Supervisors: Professor Ashley Bush and Professor Colin Masters.
-September 2012- to June 2015: Senior Research Officer at the Oxidation Disorders Laboratory, The Florey Institute of Neuroscience and Mental Health, The University of Melbourne. Melbourne, Australia. Supervisor: Professor Ashley Bush.
-June 2015- to date: Research Fellow at the Oxidation Disorders Laboratory, The Florey Institute of Neuroscience and Mental Health, The University of Melbourne. Melbourne, Australia. Supervisor: Professor Ashley Bush.

4. PhD SCIENTIFIC VISITS
-2000 (June-September). Laboratory for Oxidation Biology, Genetics and Aging Unit, Massachusetts General Hospital, Harvard Medical School, Charlestown, USA.
-2001 (January). Laboratory for Oxidation Biology, Genetics and Aging Unit, Massachusetts General Hospital, Harvard Medical School, Charlestown, USA.
-2001 (February-May). Neuropathology Laboratory of Mental Health Research Institute of Victoria and Department of Pathology, The University of Melbourne. Melbourne, Australia.

5. POST-GRADUATE COURSES:
-1995. Two hybrid system: A genetic molecular approach applied to study cellular function. (Director, Dr. Sigmund Fischer, INSERM, Francia), Faculty of Sciences, University of Chile. Santiago, Chile.
-1999. X-Ray Cristalography of Biology Molecules. (Director, Dr. Debashis Ghosh,Hauptman-Woodward Medical Research Institute, Buffalo, New York, U.S.A.), Faculty of Biological Sciences, Catholic University of Chile, Santiago, Chile.
-1999. ICRO-UNESCO COURSE: " Biology and pathology of free radicals: plant & wine npolyphenol antioxidants". (Director, Dr. Federico Leighton, Catholic Universy of Santiago, Chile). Faculty of Biological Science, P. Catholic University of Chile, Santiago, Chile.
-1999. Iron and Copper Homeostasis. (Director Dr Marco Tulio Núñez, University of Chile, Chile), Faculty of Sciences, University of Chile, Santiago, Chile.

6. SELECTED AWARDS AND FELLOWSHIPS
-1987-1995:     President Republic Fellowship, Chilean Government.
-1998-2001:     CONICYT Fellowship, Chilean Government.
-2004:         Travel Award from Alzheimer´s Association, "The 9th Internacional Conference on Alzheimer's Disease and Related Disorders", Philadelphia, Pennsylvania, USA.
-2005:               Fundación Andes Fellowship for Young Chilean Researchers.
-May 2006 to December 2011. Honorary Research Fellow, MHRI, Melbourne, Australia.
-October 2007. Fellowship from, "The International Society for Neurochemistry" to attend to "Protein Misfolding & Neurological Disorders Meeting, Dunk Island, Australia, October 17-19th.
-January 2008 to December 2010. University Academic Award, Universidad de Concepción, Chile
-January 2009. "Outstanding Academic qualification", Facultad de Ciencias Biológicas, Universidad Concepción, Chile
-January  2010. Associate Professor, Universidad de Concepción, Chile.


7. RESEARCH GRANT
-1999-2001. FONDECYT Grant 2990087 (PI. PhD Thesis, Chile). 
-2005-2007. Fundación Andes Grant C-14060-77 (PI, Chile)
-2006-2007. FONDECYT Grant 1060368 (Co-PI, Chile).
-2007-2009. Anillo-PBCT Grant ACT-04 (Main Researcher, Chile).
-2010-2012. FONDECYT Grant 1100502 (Co-PI, Chile).
-2011-2012. CMA Bío Bío (Executive Director).
-2013. Pierce Armstrong Foundation (Equipment grant).
-2015. Pierce Armstrong Foundation (Equipment grant).
-2016-2018. ARC DP 160100325 (CI)
-2019-2021. ARC DP 190102573 (CI)

8. SCIENTIFIC IMPACT: 46 ISI PUBLICATIONS AND ~2,000 CITATIONS.


9. H-INDEX: 26 (ISI WEB OF KNOWLEDGE)


10. ISI PUBLICATIONS  
1. Reyes JG, Díaz A, Osses N, Opazo C, Benos DJ (1997) On stage single cell identification of rat spermatogenic cells. Biol Cell 89: 53-66.

2. Alvarez A, Opazo C, Alarcón R, Garrido J, Inestrosa NC (1997) Acetylcholinesterase promotes the aggregation of amyloid--peptide fragments by forming a complex with the growing fibrils. J Mol Biol 272: 348-361. (High citation).

3. Opazo C, Inestrosa NC (1998) Cross-linking of amyloid--peptide to brain acetylcholinesterase. Mol Chem Neuropathol 33: 39-49.

4. Berríos J, Osses N, Opazo C, Arenas G, Mercado L, Benos DJ, Reyes JG (1998) Intracellular Ca2+ homeostasis in rat round spermatids. Biol Cell 90: 391-398.

5. Alvarez A, Alarcón R, Opazo C, Campos E, Muñoz FJ, Calderón F, Dajas F, Gentry MK, Doctor BP, De Mello FG, Inestrosa NC (1998) Stable complexes involving acetylcholinesterase and amyloid--petide change the biochemical properties of the enzyme and increase the neurotoxicity of Alzheimer´s fibrils. J Neurosci 18: 3213-3223. (High citation).

6. Ruiz FH, Gonzalez M, Bodini M, Opazo C, Inestrosa NC (1999) Cysteine 144 is a key residue in the copper reduction by the -amyloid precursor protein. J Neurochem 73: 1288-1292. 

7. Opazo C, Ruiz FH, Inestrosa NC (1999) Amyloid--peptide reduces copper (II) to copper(I) independent of its aggregation state. Biol Res 34: 125-131.

8. Miranda S, Opazo C, Larrondo LF, Munoz FJ, Ruiz F, Leighton F, Inestrosa NC (2000) The role of oxidative stress in the toxicity induced by amyloid -peptide in Alzheimer's disease. Prog Neurobiol 62: 633-648. (High citation).

9. Muñoz FJ, Opazo C, Gil-Gómez G, Tapia G, Fernández V, Valverde MA, Inestrosa NC (2002) Vitamin E but not 17-Estradiol protect against vascular toxicity induced by -amyloid wild-type and the Dutch amyloid variant. J Neurosci 22: 3081-3089.

10. Opazo C, Huang X, Cherny RA, Moir RD, Roher AE, White AR, Cappai R, Masters CL, Tanzi RE, Inestrosa NC, Bush AI (2002) Metalloenzyme-like activity of Alzheimer's disease -amyloid. Cu-dependent catalytic conversion of dopamine, cholesterol, and biological reducing agents to neurotoxic H2O2. J Biol Chem 277: 40302-40308. (High citation).

11. Opazo CM, Barría, MI, Ruiz FH, Inestrosa NC (2003) Copper Reduction by Copper Binding Proteins and its Relation to Neurodegenerative Diseases. Biometals 16: 91-98. 

12. Cerpa WF, Barría MI, Chacón MA, Opazo C, Suazo M, González M, Bush AI, Inestrosa NC (2004) The N-terminal Cu-binding domain of the amyloid precursor protein of Alzheimer's disease protects against Cu2+-neurotoxicity in vivo. FASEB J 18:1701-1703.

13. Puglielli L, Friedlich AL, Setchell KDR, Nagano S, Opazo C, Cherny RA, Barnham KJ, Wade JD, Melov SM, Kovacs DM, Bush AI (2005) Alzheimer's disease -amyloid activity mimics cholesterol oxidase. J Clin Invest 115: 2556-2563. 

14. Opazo C, Luza S, Villemagne VL, Volitakis I, Rowe C, Barnham KJ, Strozyk D, Masters CL, Cherny RA, Bush AI (2006) Radioiodinated clioquinol as a biomarker for -amyloid:Zn2+ complexes in Alzheimer's disease   Aging Cell 5: 69-79. 

15. Minniti AN, Rebolledo DL, Grez PM, Fadic R, Aldunate R, Volitakis I, Cherny RA, Opazo C, Masters C, Bush AI, Inestrosa NC (2009) Intracellular amyloid formation in muscle cells of A-transgenic Caenorhabditis elegans: determinants and physiological role in copper detoxification. Mol Neurodegener 4:2.

16. Sepúlveda FJ, Opazo C, Aguayo LG (2009) Alzheimer -amyloid blocks epileptiform activity in hippocampal neurons. Mol Cell Neurosci 41:420-428.

17. Parodi J, Sepúlveda FJ, Roa J, Opazo C, Inestrosa NC, Aguayo LG (2010) -amyloid causes depletion of synaptic vesicles leading to neurotransmission failure. J Biol Chem 285:2506-2514. 

18. Avila ME, Sepulveda FJ, Burgos CF, Moraga-Cid G, Parodi J, Moon RT, Aguayo LG, Opazo C, De Ferrari GV (2010) Canonical Wnt3a modulates intracellular calcium and enhances excitatory neurotransmission in hippocampal neurons. J Biol Chem 285:18939-47.

19. Sepúlveda FJ, Parodi J, Peoples RW, Opazo C, Aguayo LG (2010) Synaptotoxicity of Alzheimer -amyloid can be explained by its membrane perforating property. PLoS ONE 5:e11820.

20. Cuevas ME, Haensgen H, Sepúlveda FJ, Zegers G, Roa J, Opazo C, Aguayo LG (2011) Soluble Aβ1-40 peptide increases excitatory neurotransmission and induces epileptiform activity in hippocampal neurons. J Alzheimers Dis 23:673-87.

21. Peters C, Muñoz B, Sepúlveda FJ, Urrutia J, Quiroz M, Luza S, De Ferrari GV, Aguayo LG, Opazo C (2011) Biphasic effects of copper on neurotransmission in rat hippocampal neurons. J Neurochem 119:78-88

22. Pacheco C, Aguayo LG, Opazo C (2012) An extracellular mechanism that can explain the neurotoxic effects of α-synuclein aggregates in the brain. Front Physiol 3:297.

23. Alarcón MA, Medina MA, Hu Q, Avila ME, Bustos BI, Pérez-Palma E, Peralta A, Salazar P, Ugarte GD, Reyes AE, Martin GM, Opazo C, Moon RT, De Ferrari GV (2013) A novel functional low-density lipoprotein receptor-related protein 6 gene alternative splice variant is associated with Alzheimer's disease. Neurobiol Aging 34:1709.e9-1709.e18.

24. Zurita MP, Muñoz G, Sepúlveda FJ, Gómez P, Castillo C, Burgos CF, Fuentealba J, Opazo C, Aguayo LG. (2013) Ibuprofen Inhibits the Synaptic Failure Induced by the Amyloid-β Peptide in Hippocampal Neurons. J Alzheimers Dis 35:463-73.

25. Peters C, Fernandez-Perez EJ, Burgos CF, Espinoza MP, Castillo C, Urrutia JC, Streltsov VA, Opazo C, Aguayo LG (2013) Inhibition of amyloid -induced synaptotoxicity by a pentapeptide derived from the glycine zipper region of the neurotoxic peptide. Neurobiol Aging 34:2805-14.

26. Tajes M, ILL-Raga G, Palomer E, Ramos-Fernández E, Guix FX, Bosch-Morató M, Guivernau B, Jiménez-Conde J, Ois A, Pérez-Asensio F, Reyes-Navarro M, Caballo C, Galán AM, Alameda F, Escolar G, Opazo C, Planas A, Roquer J, Valverde MA, Muñoz FJ (2013) Nitro-Oxidative Stress after Neuronal Ischemia Induces Protein Nitrotyrosination and Cell Death. Oxid Med Cell Longev 2013:826143. doi: 10.1155/2013/826143.

27. Sepúlveda FJ, Fierro H, Fernandez E, Castillo C, Peoples RW, Opazo C, Aguayo LG (2014) Nature of the neurotoxic membrane actions of amyloid-β on hippocampal neurons in Alzheimer's disease. Neurobiol Aging 35:472-81.

28. Acevedo KM, Opazo CM, Norrish D, Challis LM, Li QX, White AR, Bush AI, Camakaris J (2014) Phosphorylation of Amyloid Precursor Protein at Threonine 668 Is Essential for Its Copper-responsive Trafficking in SH-SY5Y Neuroblastoma Cells. J Biol Chem 289:11007-19. 

29. Bustos FJ, Varela-Nallar L, Campos M, Henriquez B, Phillips M, Opazo C, Aguayo LG, Montecino M, Constantine-Paton M, Inestrosa NC, van Zundert B (2014) PSD95 Suppresses Dendritic Arbor Development in Mature Hippocampal Neurons by Occluding the Clustering of NR2B-NMDA Receptors. PLoS One 9(4):e94037. doi: 10.1371/journal.pone.0094037. 

30. Pérez-Palma E, Bustos BI, Villamán CF, Alarcón MA, Avila ME, Ugarte GD, Reyes AE, Opazo C, De Ferrari GV (2014) Alzheimer's Disease Neuroimaging Initiative; NIA-LOAD/NCRAD Family Study Group. Overrepresentation of glutamate signaling in Alzheimer's disease: network-based pathway enrichment using meta-analysis of genome-wide association studies. PLoS One 9(4):e95413. doi: 10.1371/journal.pone.0095413. 

31. Ramírez AE, Pacheco CR, Aguayo LG, Opazo CM (2014) Rapamycin protects against Aβ-induced synaptotoxicity by increasing presynaptic activity in hippocampal neurons. Biochim Biophys Acta 1842:1495-1501.

32. Opazo CM, Greenough MA, Bush AI (2014) Copper: From neurotransmission to neuroproteostasis. Front. Aging Neurosci 6:143.

33. Castro PA, Ramirez A, Sepúlveda FJ, Peters C, Fierro H, Waldron J, Luza S, Fuentealba J, Muñoz FJ, De Ferrari GV, Bush AI, Aguayo LG, Opazo C (2014) Copper-uptake is critical for the down regulation of synapsin and dynamin induced by neocuproine: modulation of synaptic activity in hippocampal neurons. Front. Aging Neurosci 6:319.

34. Vicario-Orri E, Opazo C, Francisco J. Muñoz (2015) The Pathophysiology of Axonal Transport in Alzheimer's Disease. J. Alzheimers. Dis. 43:1097-113.

35. Gallegos S, Pacheco C, Peters C, Opazo CM, Aguayo LG (2015) Features of -synuclein that could explain the progression and irreversibility of Parkinson's disease. Front Neurosci. 9:59.

36. Pacheco CR, Morales CN, Ramírez AE, Muñoz FJ, Gallegos SS, Caviedes PA, Aguayo LG, Opazo CM (2015) Extracellular α-synuclein alters synaptic transmission in brain neurons by perforating the neuronal plasma membrane. J Neurochem. 132:731-41.

37. Peters C, Espinoza MP, Gallegos S, Opazo C, Aguayo LG (2015) Alzheimer's Aβ interacts with cellular prion protein inducing neuronal membrane damage and synaptotoxicity. Neurobiol Aging. 36:1369-77. 

38. Ill-Raga G, Palomer E, Ramos-Fernández E, Guix FX, Bosch-Morató M, Guivernau B, Tajes M, Valls-Comamala V, Jiménez-Conde J, Ois A, Pérez-Asensio F, Reyes-Navarro M, Caballo C, Gil-Gómez G, Lopez-Vilchez I, Galan AM, Alameda F, Escolar G, Opazo C, Planas AM, Roquer J, Valverde MA, Muñoz FJ (2015) Fibrinogen nitrotyrosination after ischemic stroke impairs thrombolysis and promotes neuronal death. Biochim Biophys Acta.1852:421-8. 

39. Muñoz G, Urrutia JC, Burgos CF, Silva V, Aguilar F, Sama M, Yeh HH, Opazo C, Aguayo LG (2015) Low concentrations of ethanol protect against synaptotoxicity induced by Aβ in hippocampal neurons. Neurobiol Aging. 36:845-56. 

40. Peters C, Bascuñán D, Opazo C, Aguayo LG (2016) Differential Membrane Toxicity of Amyloid-β Fragments by Pore Forming Mechanisms. J. Alzheimers. Dis. 51:689-99.

41. Greenough MA, Ramírez Munoz A, Bush AI, Opazo CM (2016) Metallo-pathways to Alzheimer's disease: lessons from genetic disorders of copper trafficking. Metallomics. 8:831-9.

42. Medina M, Andrade V, Caracci M, Avila M, Verdugo D, Vargas M, Ugarte G, Reyes A, Opazo C, De Ferrari GV (2018) Wnt/-catenin signaling stimulates the expression and synaptic clustering of the autism-associated Neuroligin 3 gene. Transl. Psychiatry 8:45.


43. Bousman CA, Luza S, Mancuso SG, Kang D, Opazo CM, Mostaid MS, Cropley V, McGorry P, Shannon Weickert C, Pantelis C, Bush AI, Everall IP (2019) Elevated ubiquitinated proteins in brain and blood of individuals with schizophrenia. Sci Rep. 9:2307.

44. Meiklejohn H, Mostaid MS, Luza S, Mancuso SG, Kang D, Atherton S, Rothmond DA, Weickert CS, Opazo CM, Pantelis C, Bush AI, Everall IP, Bousman CA (2019) Blood and brain protein levels of ubiquitin-conjugating enzyme E2K (UBE2K) are elevated in individuals with schizophrenia. J Psychiatr Res. 113:51-57.

45. Acevedo K, Masaldan S, Opazo CM, Bush AI (2019) Redox active metals in neurodegenerative diseases. J Biol Inorg Chem. 24:1141-1157.

46. Luza S, Opazo CM, Bousman CA, Pantelis C, Bush AI, Everall IP (2020). The ubiquitin proteasome system and schizophrenia. Lancet Psychiatry. doi.org/10.1016/S2215-0366(19)30520-6.


11. NON ISI PUBLICATIONS

Opazo C (2005) Metales de transición y la enfermedad de Alzheimer. Rev Esp Geriatr Gerontol 40: 365-370.

Opazo, C. and Nualart, F (2011) Tendencias en Microscopía Láser, Biomedical Science 2, 21-25.


12. BOOK CHAPTERS

1. Evin G, Sernee MF, Barnham KJ, Holsinger RMD, Culvenor JG, Hoke DE, Li Q-X, Smith D, Maynard C, Tickler A, Huang X, Opazo C, Carrington D, Kocak G, Volitakis I, Mok S-S, Ciccotosto G, Williamson NA, Beyreuther K, Wade J, Curtain CC, Cherny RA, Bush AI, Masters CL, Cappai R (2003)  Modulation of Alzheimer's Disease Aß pathways for Rational Therapeutic Intervention: Secretase Inhibition and Metalloprotein Active Compounds. In: Iqbal, K. and Winblad, B. eds. Alzheimer's Disease and Related Disorders: Research Advances. Publishers: Ana Aslan" International Academy of Aging- Bucharest Romania, 513-523.

2. Inestrosa NC, De Ferrari G, Opazo C, Alvarez A (2004) Neurodegenerative processes in Alzheimer's disease: role of A-AChE complexes and Wnt signaling. In Cholinergic Mechanisms: Mechanism, Function and Dysfunction, Chapter 51: 1-6.

3. Villemagne VL, Cappai R, Barnham KJ, Cherny RA, Opazo C, Novakovic KE, Rowe CC, Masters CL. (2007) The A-centric pathway of Alzheimer's disease. A and Alzheimer's Disease. En: A peptide and Alzheimer's Disease. Springer-Verlag (London). Editado por Colin Burrow y David H Small. 

4. Opazo C, Castro P, Waldron J, Parodi J, Fuentealba J, Aguayo LG (2008) Zn2+-protein interactions in normal brain physiology and neuropathology. In: Neurodegenerative Diseases: From Molecular Concepts to Therapeutic Targets. Nova Science Publishers, Inc. Editado por Rommy von Bernhardi y Nibaldo C. Inestrosa. pp. 177-187

5. Aguayo LG, Parodi J, Sepúlveda FJ, Roa J, Opazo C (2008) Inhibitory Effects of-amyloid Aggregates on Synaptic Transmission in Hippocampal Neurons. In: Neurodegenerative Diseases: From Molecular Concepts to Therapeutic Targets. Nova Science Publishers, Inc. Editado por Rommy von Bernhardi y Nibaldo C. Inestrosa. 

6. Aguayo LG, Parodi J, Sepúlveda FJ, Opazo C (2009) Pore Forming Neurotoxin-like Mechanism for A-Induced Synaptic Failure. In Hypothesis and Research Milestones in Alzheimer's Disease.  Eds. George Perry and Ricardo Maccioni. Springer. p13.

7. Aguayo LG, Parodi J, Sepúlveda FJ, Opazo C (2010) Inhibitory effects of -amyloid aggregates on synaptic transmission in hippocampal neurons. In Hippocampus: Anatomy, Functions and Neurobiology. Eds. Garner A and Frantz D. Nova Science Publishers, Inc. p 167-179.

8. Ramírez AM, Greenough MA, Bush AI, Opazo CM (2016) Metalloregulation of protein clearance: New therapeutics avenues for neurodegenerative diseases. In Biometals in Neurodegenerative Diseases: Mechanisms and Therapeutics. Eds. White AR, Aschner M, Costa LG and Bush AI.




1


